Frank Clyburn is of Revolution Medicines, Inc.. Currently has a direct ownership of 9,738 shares of RVMD, which is worth approximately $360,500. The most recent transaction as insider was on Jun 26, 2025, when has been sold 2,806 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.74K
40.48% 3M change
n/a 12M change
Total Value Held $360,500

Frank Clyburn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 26 2025
BUY
Grant, award, or other acquisition
-
2,806 Added 22.37%
9,738 Common Stock
Aug 05 2024
BUY
Grant, award, or other acquisition
-
6,932 Added 50.0%
6,932 Common Stock

Also insider at

MRK
Merck & Co., Inc. Healthcare
IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC Basic Materials
ABC
AMERISOURCEBERGEN CORP Healthcare
DD
DuPont de Nemours, Inc. Basic Materials
FC

Frank Clyburn

Kenilworth, NJ

Track Institutional and Insider Activities on RVMD

Follow Revolution Medicines, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVMD shares.

Notify only if

Insider Trading

Get notified when an Revolution Medicines, Inc. insider buys or sells RVMD shares.

Notify only if

News

Receive news related to Revolution Medicines, Inc.

Track Activities on RVMD